Posted by Michael Wonder on 06 Aug 2018
EpiPen shortage is critical – and not easy to fix
2 August 2018 - An estimated 2.6 million Canadians suffer from serious allergies and about 630,000 of them carry an epinephrine auto-injector, a medication used for the emergency treatment of life-threatening allergic reaction.
Only one brand of auto-injector, EpiPen, is available in this country and it is in such short supply that, “in the coming days or weeks,” there could be none available for purchase, according to Health Canada.
Severe allergy sufferers are alarmed, and rightfully so. It’s disconcerting (to say the least) to go to your local pharmacy and be told your lifesaving medicine is out-of-stock.
